137 related articles for article (PubMed ID: 22849409)
1. Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis.
Moussa MM; Mowafy N
J Gastroenterol Hepatol; 2013 Feb; 28(2):335-41. PubMed ID: 22849409
[TBL] [Abstract][Full Text] [Related]
2. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.
Fenaux P; Muus P; Kantarjian H; Lyons RM; Larson RA; Sekeres MA; Becker PS; Orejudos A; Franklin J
Br J Haematol; 2017 Sep; 178(6):906-913. PubMed ID: 28616874
[TBL] [Abstract][Full Text] [Related]
3. Is There a Role for Biweekly Romiplostim in the Management of Chronic Immune Thrombocytopenia (ITP)? A Report of Three Cases.
Rooprai JK; Khamisa K
Case Rep Hematol; 2018; 2018():6037494. PubMed ID: 30524761
[TBL] [Abstract][Full Text] [Related]
4. Relationship between response to lusutrombopag and splenic volume.
Uojima H; Arase Y; Itokawa N; Atsukawa M; Satoh T; Miyazaki K; Hidaka H; Sung JH; Kako M; Tsuruya K; Kagawa T; Iwakiri K; Horie R; Koizumi W
World J Gastroenterol; 2018 Dec; 24(46):5271-5279. PubMed ID: 30581275
[TBL] [Abstract][Full Text] [Related]
5. Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells.
Fan X; Krzyzanski W; Wong RSM; Liu D; Yan X
ACS Pharmacol Transl Sci; 2023 Dec; 6(12):1884-1897. PubMed ID: 38093847
[TBL] [Abstract][Full Text] [Related]
6. Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers.
Moufarrij S; O'Cearbhaill RE; Zhou Q; Iasonos A; Mantha S; Zwicker J; Wilkins CR
Gynecol Oncol Rep; 2024 Jun; 53():101399. PubMed ID: 38757118
[TBL] [Abstract][Full Text] [Related]
7. Myelofibrosis associated with romiplostim treatment in a patient with immune thrombocytopenia.
Gonzalez MF; Freeman JK
Case Rep Hematol; 2012; 2012():318597. PubMed ID: 22937324
[TBL] [Abstract][Full Text] [Related]
8. Leukemic mature B-cell neoplasm observed during the treatment with romiplostim in patient with thrombocytopenia and liver cirrhosis.
Osawa M; Akiyama H; Mae S; Fujiwara Y; Yamane M
Clin Case Rep; 2018 Jun; 6(6):1087-1089. PubMed ID: 29881570
[TBL] [Abstract][Full Text] [Related]
9. Purification and Activity Evaluation of a Novel Thrombopoietin Mimetic Peptide.
Liang Y; Li Y; Ma R; Duan C
J Pharm Sci; 2024 Feb; 113(2):359-365. PubMed ID: 38006944
[TBL] [Abstract][Full Text] [Related]
10. A New Tool to Assess the Epidemiology of Immune Thrombocytopenia: The Nordic Country Patient Registry for Romiplostim.
Moulis G
EClinicalMedicine; 2019 Sep; 14():11-12. PubMed ID: 31709396
[No Abstract] [Full Text] [Related]
11. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
Afdhal NH; Giannini EG; Tayyab G; Mohsin A; Lee JW; Andriulli A; Jeffers L; McHutchison J; Chen PJ; Han KH; Campbell F; Hyde D; Brainsky A; Theodore D;
N Engl J Med; 2012 Aug; 367(8):716-24. PubMed ID: 22913681
[TBL] [Abstract][Full Text] [Related]
12. Romiplostim in the management of the thrombocytopenic surgical patient.
Marshall AL; Goodarzi K; Kuter DJ
Transfusion; 2015 Oct; 55(10):2505-10. PubMed ID: 26033367
[TBL] [Abstract][Full Text] [Related]
13. The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current Evidence.
Qureshi K; Patel S; Meillier A
Int J Hepatol; 2016; 2016():1802932. PubMed ID: 27800187
[TBL] [Abstract][Full Text] [Related]
14. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.
Maan R; de Knegt RJ; Veldt BJ
Drugs; 2015 Nov; 75(17):1981-92. PubMed ID: 26501978
[TBL] [Abstract][Full Text] [Related]
15. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
Terrault N; Chen YC; Izumi N; Kayali Z; Mitrut P; Tak WY; Allen LF; Hassanein T
Gastroenterology; 2018 Sep; 155(3):705-718. PubMed ID: 29778606
[TBL] [Abstract][Full Text] [Related]
16. Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.
Minowa K; Arai K; Kasahara M; Sakamoto S; Shimizu H; Nakano N; Ito R; Obayashi N; Nakazawa A; Ishiguro A
Pediatr Transplant; 2014 Sep; 18(6):E212-5. PubMed ID: 25041553
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative haematological assessment in patients scheduled for major surgery.
Muñoz M; Gómez-Ramírez S; Kozek-Langeneker S
Anaesthesia; 2016 Jan; 71 Suppl 1():19-28. PubMed ID: 26620143
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
Levy JH; Welsby I; Goodnough LT
Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955
[TBL] [Abstract][Full Text] [Related]
19. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss.
Ker K; Prieto-Merino D; Roberts I
Br J Surg; 2013 Sep; 100(10):1271-9. PubMed ID: 23839785
[TBL] [Abstract][Full Text] [Related]
20. Lusutrombopag: First Global Approval.
Kim ES
Drugs; 2016 Jan; 76(1):155-8. PubMed ID: 26666417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
